| 1995 |
Cdx1 knockout mice exhibit anterior homeotic transformations of vertebrae, concomitant with posterior shifts of Hox gene expression domains in somitic mesoderm. Putative Cdx1-binding sites were identified in Hox gene control regions, and in vitro transactivation of Hoxa-7 by Cdx1 was demonstrated, indicating direct regulation of Hox genes by Cdx1. |
Homologous recombination (gene knockout), skeletal phenotype analysis, in vitro transactivation assay |
Cell |
High |
7585967
|
| 2000 |
Cdx1 is a direct transcriptional target of the Wnt/β-catenin signaling pathway. The Cdx1 promoter contains functional Tcf-binding motifs that bind Tcf/Lef1/β-catenin complexes and mediate β-catenin-dependent transactivation. Tcf4-deficient mouse embryos show abrogation of Cdx1 protein in the small intestinal epithelium. |
Promoter-reporter assays, gel shift assays, Tcf4-knockout mouse analysis, Wnt stimulation of ES cells and embryonic endoderm |
Development (Cambridge, England) |
High |
10934025
|
| 2000 |
Cdx1 is a direct retinoic acid (RA) target gene. RA regulation of Cdx1 occurs through an atypical RA response element (RARE) in the proximal Cdx1 promoter, providing an indirect mechanism by which retinoid signaling impacts Hox expression and vertebral patterning. |
Promoter-reporter assays, retinoid receptor binding studies, in vitro RA treatment |
Molecular and cellular biology |
High |
10938132
|
| 2001 |
Cdx1 expression is regulated by multiple pathways: (1) direct retinoid signaling through an atypical RARE at early stages; (2) Wnt3a signaling through functional LEF/TCF response elements at later stages; and (3) an autoregulatory loop in which Cdx1 positively regulates its own expression. Wnt3a and RA synergize strongly to activate Cdx1. |
Promoter-reporter assays, LEF/TCF motif mutagenesis, Wnt3a hypomorph (vestigial tail) mouse analysis, RA treatment experiments |
Developmental biology |
High |
11784033
|
| 2001 |
Wnt-3a is required for normal cdx-1 expression in the primitive streak and tail bud region. Loss of Wnt-3a signaling leads to reduced Cdx1 expression and anterior homeotic vertebral transformations, placing Wnt-3a upstream of cdx-1 in anteroposterior patterning. |
Wnt3a mutant mouse analysis, in situ hybridization for Cdx1 expression |
Mechanisms of development |
Medium |
11335109
|
| 2000 |
Cdx1 inhibits intestinal epithelial cell (IEC-6) proliferation by causing G0/G1 arrest through marked reduction of cyclin D1 and D2 protein levels, leading to increased hypophosphorylated Rb and p130. Cyclin-dependent kinase inhibitors (p16, p18, p21, p27, p57) were not affected. |
Stable transfection of inducible Cdx1 constructs and adenoviral expression in IEC-6 cells, flow cytometry, Western blot for cell cycle proteins |
The Journal of biological chemistry |
High |
10660624
|
| 1999 |
Cdx1 expression in IEC-6 intestinal epithelial cells promotes differentiation toward a columnar enterocyte phenotype, including induction of aminopeptidase N and villin expression, redistribution of actin filaments to the cortex, and formation of multilayers with apical microvilli. Cdx1 also increased proliferation rate, resistance to apoptosis, and migration speed. |
Stable transfection of Cdx1 in IEC-6 cells, morphological analysis, immunofluorescence, in vitro wound assay |
Gastroenterology |
Medium |
10579974
|
| 2001 |
Cdx1 expression in IEC-6 intestinal epithelial cells induces anchorage-independent growth and adenocarcinoma formation in vivo. These oncogenic effects correlate with increased GTP-bound Ras, modulation of Cdc42 and RhoA activities, and accumulation of PI3 kinase products. Combined inhibition of Ras/Rho and PI3 kinase signaling blocked colony formation. |
Stable transfection, soft agar assay, in vivo tumor formation, GTP-pulldown assays, PI3K inhibitor treatment |
Oncogene |
Medium |
11464284
|
| 2001 |
Cdx1 directly activates the PAP I (Pancreatitis Associated Protein I) promoter through a Cdx1-binding element, as demonstrated by promoter binding and deletion analysis. PAP I in turn acts as a proliferative factor for intestinal cells via an autocrine/paracrine mechanism, mediating part of the Cdx1-induced growth effect. |
Stable transfection, gel shift assay, promoter deletion analysis, antisense knockdown of PAP I, adenoviral PAP I overexpression |
European journal of cell biology |
Medium |
11302520
|
| 2002 |
Cdx1 and Cdx2 cooperate in anteroposterior vertebral patterning and posterior axis elongation. Compound Cdx1 null/Cdx2 heterozygous mutants show extensive homeotic transformations along the entire vertebral column and posterior truncation, associated with early alterations in Hox gene expression boundaries in the somitic mesoderm. |
Generation of compound Cdx1/Cdx2 mutant mice, skeletal analysis, Hox gene expression by in situ hybridization |
Development (Cambridge, England) |
High |
11959827
|
| 2003 |
RARE-null (retinoic acid response element-null) Cdx1 mutant mice exhibit reduced Cdx1 expression, vertebral homeotic transformations, and altered Hox gene expression similar to a subset of Cdx1-null defects, demonstrating that the RARE in the Cdx1 proximal promoter is functionally required in vivo for a specific subset of Cdx1 expression and function. |
Targeted mutation of the RARE in the Cdx1 promoter in mice, skeletal analysis, Hox expression analysis |
Development (Cambridge, England) |
High |
14660544
|
| 2004 |
Cdx1 autoregulation occurs through a novel physical interaction between the homeodomain of Cdx1 and the B box of LEF1. Cdx1 and LEF1 synergize to induce Cdx1 expression from its own promoter through LEF/TCF response elements. This was confirmed in vivo by Cdx1/Wnt3a(vt) compound mutants showing convergent effects on Cdx1 expression and vertebral patterning. |
Co-immunoprecipitation, promoter-reporter assays, domain-swap experiments, Cdx1/Wnt3a compound mutant mouse analysis |
Molecular and cellular biology |
High |
15143193
|
| 2004 |
Cdx1 or Cdx2 expression inhibits β-catenin/TCF transcriptional activity in colon cancer cells in a dose-dependent manner, reducing colon cancer cell proliferation. This inhibitory effect does not alter β-catenin protein levels or intracellular distribution, and does not induce an inhibitory TCF isoform. |
Transfection of Cdx1/Cdx2 expression constructs, TCF/β-catenin reporter assays, Western blot, proliferation assays |
The Journal of biological chemistry |
Medium |
15215241
|
| 2004 |
Loss of CDX1 expression in colorectal carcinoma is primarily regulated by promoter methylation. All CRC cell lines lacking CDX1 mRNA had a methylated CDX1 promoter, and demethylation with 5-aza-2'-deoxycytidine restored CDX1 expression. No coding mutations or LOH explained the loss of expression. |
Methylation-specific PCR, RT-PCR, demethylation treatment, LOH analysis, mutation analysis in 37 CRC cell lines |
Proceedings of the National Academy of Sciences of the United States of America |
High |
14704280
|
| 2004 |
CDX1 directly regulates the KRT20 (Cytokeratin 20) promoter. ChIP analysis confirmed CDX1 binding to predicted CDX elements within 246 bp upstream of the KRT20 transcription start site in vivo. CDX1 and KRT20 expression are significantly correlated in colorectal cancer cell lines. |
Chromatin immunoprecipitation (ChIP), promoter deletion and mutation analysis, microarray, expression correlation in 38 CRC cell lines |
Proceedings of the National Academy of Sciences of the United States of America |
High |
19188603
|
| 2003 |
CDX1 specifically transactivates the glucose-6-phosphatase (Glc6Pase) promoter through its TATA box, while CDX2 cannot, because CDX1 (but not CDX2) can physically interact with the TATA-binding protein (TBP). This functional difference is mediated by the carboxy domains defining the specificity of CDX1 versus CDX2. |
Gel shift assay, mutagenesis, transient transfection reporter assays, stable transfection of CDX1 in IEC6 cells with Glc6Pase protein induction |
Nucleic acids research |
Medium |
12954759
|
| 2006 |
CDX1 interacts physically with the TATA-binding protein (TBP) via its homeodomain, and this interaction connects CDX1 to members of the TFIID and Mediator complexes. The transcriptional activation requires both the homeodomain (for TBP interaction) and the N-terminal domain upstream of the homeodomain. The carboxy domains of CDX1 and CDX2 determine their specificity, as CDX2 does not interact with TBP despite having intrinsic activation capacity. |
Co-immunoprecipitation, domain-swap experiments, altered-specificity TBP mutant transfection assays, luciferase reporter assays |
Nucleic acids research |
Medium |
17158164
|
| 2004 |
Cdx1 expression in COLO 205 colon cancer cells induces E-cadherin-dependent cell-cell adhesion and compaction. This is a specific transcriptional response; a Cdx1 mutant failed to elicit the effect. The adhesion phenotype is Ca2+-dependent and blockable by an E-cadherin-blocking antibody, but E-cadherin protein levels and intracellular distribution were unchanged by Cdx1. |
Stable transfection of Cdx1 in COLO 205 cells, blocking antibody experiments, electron microscopy, proliferation and gene expression assays |
American journal of physiology. Gastrointestinal and liver physiology |
Medium |
14977637
|
| 2007 |
Cdx1 and Cdx2 expression in COLO 205 cells induces E-cadherin-mediated cell adhesion by reducing tyrosine phosphorylation of β-catenin and p120-catenin. Restoring tyrosine phosphorylation (by knocking down protein tyrosine phosphatase 1B) in Cdx2-expressing cells significantly reduced cell-cell adhesion, demonstrating the functional relevance of this mechanism. |
Stable transfection, co-immunoprecipitation, tyrosine phosphorylation-specific Western blot, siRNA knockdown of PTP1B, migration/invasion assays |
American journal of physiology. Gastrointestinal and liver physiology |
Medium |
17463179
|
| 2007 |
LRE (LEF/TCF response element) mutation in the Cdx1 proximal promoter is sufficient to phenocopy Cdx1-null vertebral defects in mice, demonstrating that Wnt signaling is the key mediator of Cdx1 expression in vivo. Mutation of LRE also greatly reduced RA-induced Cdx1 expression, demonstrating that Wnt signaling is required for retinoid regulation of Cdx1. |
Generation of LRE-null and LRE+RARE-null knock-in mice, skeletal analysis, Cdx1 expression analysis |
Development (Cambridge, England) |
High |
17537796
|
| 2009 |
Cdx1 directly represses Mafb expression in the neural tube posterior to the r6/r7 boundary, thereby refining hindbrain positional identity. ChIP analysis confirmed Cdx1 binding to regulatory sequences responsible for posterior Mafb repression. This repression is transient; after the 10-somite stage another mechanism restricts Mafb to r5/r6. |
In situ hybridization, immunofluorescence, chromatin immunoprecipitation (ChIP), regulatory sequence analysis in Cdx1 mutant mice |
Development (Cambridge, England) |
High |
21098558
|
| 2002 |
Wild-type p53 inhibits the transcriptional activity of the Cdx1 promoter, while the inactive p53 mutant has no effect. Cdx1 in turn inhibits p21(WAF) transcription by binding to the p21(WAF) TATA-box and activates the Bcl-2 promoter P2 through a consensus Cdx-binding site, making Cdx1-overexpressing cells more resistant to adriamycin-induced apoptosis. |
Promoter-reporter assays, transient transfection in IEC-6 and SW480 cells, apoptosis assays |
Biochemical and biophysical research communications |
Medium |
12270138
|
| 2007 |
CDX1 protein interacts with SMAD3 independently of SMAD4, and this interaction inhibits SMAD3/SMAD4-dependent transcription by 10-fold. CDX2, by contrast, stimulates SMAD3 transcriptional activity 5-fold. These distinct interactions with SMAD3 underlie the differential effects of CDX1 and CDX2 on intestinal inflammation responses. |
Co-immunoprecipitation, GST-pulldown, luciferase reporter assays |
Gut |
Medium |
17595234
|
| 2005 |
COUP-TF (chicken ovalbumin upstream promoter-transcription factor) members antagonize RA-induced Cdx1 expression by competing with RXR-RAR heterodimers for binding to the Cdx1 RA response element, providing a repressor mechanism that restricts Cdx1 expression to the caudal embryo at E8.5. |
Promoter-reporter assays, binding competition experiments, in situ hybridization showing COUP-TF expression in anterior domains lacking Cdx1 |
The Journal of biological chemistry |
Medium |
15677473
|
| 2009 |
Cdx2 substituted into the Cdx1 locus (knock-in) perfectly complements the Cdx1-null skeletal phenotype, demonstrating that Cdx1 and Cdx2 are functionally equivalent for vertebral patterning in paraxial mesoderm. This functional redundancy is context-dependent, as shown by later work on intestinal transcriptional specificity. |
Cdx2 knock-in replacing Cdx1 locus in mice, skeletal analysis, Hox gene expression analysis, BAC transgenic overexpression |
Developmental biology |
High |
19328777
|
| 2012 |
CDX1 directly activates expression of stemness-associated reprogramming factors SALL4 and KLF5 in gastric epithelial cells. CDX1-induced SALL4 and KLF5 convert gastric epithelial cells into tissue stem-like progenitor cells that then transdifferentiate into intestinal epithelial cells. Inhibition of SALL4 or KLF5 suppresses CDX1-induced intestinal marker expression. |
ChIP-seq/microarray for CDX1 targets, siRNA knockdown of SALL4/KLF5, immunohistochemistry in human and mouse CDX1+ intestinal metaplasia |
Proceedings of the National Academy of Sciences of the United States of America |
High |
23112162
|
| 2014 |
Concomitant somatic loss of Cdx2 with a Cdx1 null allele in APC(Min/+) mice significantly increases the incidence of tumors in the distal colon, demonstrating that Cdx1 functions as a tumor suppressor specifically in the distal colon in the context of APC loss. |
Conditional somatic deletion of Cdx2 combined with Cdx1 null allele in APC(Min/+) mice, intestinal tumor analysis |
The Journal of biological chemistry |
High |
25320087
|
| 2015 |
CDX1 directly activates microRNA-215 (miR-215) transcription, as confirmed by ChIP-PCR and promoter luciferase assays. miR-215 in turn represses BMI1 and other stemness/cell-cycle genes, thereby mediating CDX1-induced differentiation and reduction of clonogenicity in colorectal cancer stem cells. |
Small RNA sequencing, quantitative ChIP-PCR, promoter luciferase assays, miR-215 overexpression/knockdown, genome-wide miR-215 target identification |
Proceedings of the National Academy of Sciences of the United States of America |
High |
25775580
|
| 2002 |
Cdx1 expression in IEC-6 cells increases apolipoprotein B mRNA editing over 10-fold, associated with a significant increase in the editing factor ACF. This links Cdx1 to developmental regulation of apoB mRNA editing during intestinal differentiation. |
Stable transfection of Cdx1 in IEC-6 cells, apoB mRNA editing quantification, ACF protein analysis, small intestine isograft developmental analysis |
The Journal of biological chemistry |
Medium |
12493769
|
| 2002 |
Oncogenic activation of the β-catenin/Tcf4 pathway in human colon cancer cells stimulates endogenous Cdx1 mRNA expression and Cdx1 promoter activity. Cdx2 exerts an inhibitory effect on both basal and β-catenin-stimulated Cdx1 promoter activity through its homeodomain, independently of canonical CDX binding sites. |
Transfection of activated β-catenin/TCF4 constructs, Cdx1 promoter-reporter assays, homeodomain mutant analysis in human colon cancer cell lines |
FEBS letters |
Medium |
11997022
|
| 2009 |
Transgenic Cdx2 induces endogenous Cdx1 expression in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach by directly binding to the unmethylated Cdx1 promoter region, as demonstrated by ChIP, EMSA, and luciferase reporter assays. siRNA-Cdx2 downregulates Cdx1 transcriptional activity, confirming Cdx2 as a direct positive regulator of Cdx1. |
Chromatin immunoprecipitation (ChIP), EMSA, luciferase reporter assays, siRNA knockdown of Cdx2, bisulfite sequencing of Cdx1 promoter |
The FEBS journal |
Medium |
19725873
|
| 2013 |
Cdx1 and Cdx2 exhibit context-dependent transcriptional specificity in the intestine. Cdx2 is significantly less potent than Cdx1 at driving transcription from the Cdx1 promoter, and knock-in of Cdx2 in the Cdx1 locus cannot substitute for Cdx1 in the autoregulatory loop in intestinal cells—in contrast to its ability to complement Cdx1 in paraxial mesoderm. |
Cell-based reporter assays, in vivo Cdx2 gene-swap (knock-in) analysis in intestinal context |
PloS one |
Medium |
23382958
|
| 2012 |
Cdx1 directly binds conserved CDX binding sites within the HoxC8 early enhancer during Xenopus embryogenesis, as demonstrated by ChIP. Cdx1 overexpression leads to precocious HoxC8 expression and knockdown to slower HoxC8 expression. The mouse HoxC8 early enhancer in Xenopus recapitulates the same Cdx1-responsive temporal expression pattern. |
Chromatin immunoprecipitation (ChIP) in Xenopus embryos, Cdx1 overexpression and morpholino knockdown, cross-species enhancer assay |
FASEB journal |
Medium |
22426122
|
| 2011 |
Cdx1 expression induces endogenous Cdx2 expression in transfected oesophageal squamous epithelial cells, suggesting a sequential CDX1→CDX2 pathway. Bile acids dose-dependently increase Cdx1 promoter activity and Cdx1 protein in oesophageal epithelial cells, upstream of CDX2 induction. |
Cdx1 expression vector transfection in oesophageal cells, Cdx1 promoter luciferase assay, immunohistochemistry in Barrett's rat model |
Gut |
Medium |
19136512
|
| 2008 |
CDX1 directly activates PPARγ gene expression at the transcriptional level through functional interaction with C/EBPα. Butyrate treatment increases the physical protein-protein interaction between CDX1 and C/EBPα, leading to enhanced PPARγ expression and intestinal cell differentiation. |
Promoter-reporter assays, co-immunoprecipitation of CDX1 and C/EBPα, butyrate treatment |
FEBS letters |
Medium |
19059241
|
| 2011 |
CDX1 and CDX2 directly bind to multiple sites in the ASBT (apical sodium-dependent bile acid transporter) gene promoter. Six CDX binding sites were verified by EMSA and ChIP assays in living cells, and CDX siRNA knockdown reduced ASBT mRNA. CDX1 and CDX2 strongly induced ASBT promoter activity in reporter assays. |
EMSA, chromatin immunoprecipitation (ChIP), siRNA knockdown, promoter-reporter assays, real-time PCR in Barrett's esophagus biopsies |
American journal of physiology. Gastrointestinal and liver physiology |
Medium |
22016432
|
| 2013 |
Oxidative stress (H2O2) silences CDX1 in colorectal cancer cells through epigenetic mechanisms: H2O2 increases CDX1 promoter methylation, upregulates DNMT1 and HDAC1 expression and activity, and enhances the physical association between DNMT1 and HDAC1. Pretreatment with the demethylation agent 5-Aza-dC reverses the H2O2-induced CDX1 silencing. |
Methylation-specific PCR, Western blot, DNMT1/HDAC1 activity assays, co-immunoprecipitation of DNMT1 and HDAC1, pharmacological inhibitor treatment |
Gene |
Medium |
23618814
|
| 2012 |
Methylation of the CDX1 promoter is associated with closed chromatin structure and reduced NF-κB binding. NF-κB binding to the CDX1 promoter is methylation-dependent, demonstrated by competitive EMSA and ChIP. Along the gastritis-metaplasia-carcinoma sequence, an inverse biphasic pattern of CDX1 promoter methylation correlates inversely with NF-κB signaling activity and CDX1 expression. |
Competitive EMSA, chromatin immunoprecipitation (ChIP), bisulfite sequencing, clinical tissue series analysis |
The American journal of pathology |
Medium |
22749770
|
| 2008 |
CDX1 and c-Myc cooperate to induce mucin production and changes in keratin expression characteristic of Barrett's esophagus when expressed in immortalized human esophageal keratinocytes cultured in organotypic models, initiating the earliest stages of transdifferentiation. |
Microarray of esophageal/Barrett's/small intestinal biopsies, organotypic culture of esophageal keratinocytes with Cdx1 and c-myc expression, morphological and marker analysis |
PloS one |
Medium |
18953412
|
| 2012 |
Multiple miRNAs (miR-9, miR-16, miR-22) induced by Cdx1 expression directly bind to the CDX2 mRNA 3'UTR to destabilize and degrade CDX2 transcripts. Simultaneous mutation of both the miR-9- and miR-16-binding sites in the CDX2 3'UTR was sufficient to block Cdx2 suppression by Cdx1. |
MiRNA microarray, luciferase 3'UTR reporter assays, 3'UTR mutant analysis in SW480 cells |
The Biochemical journal |
Medium |
22849325
|
| 2014 |
CDX1 restricts trophoblast cell invasiveness in HTR-8/SVneo cells by inhibiting MMP-9 expression and increasing TIMP-1 expression, independently of the PI3K/AKT signaling pathway. CDX1 itself is regulated by PI3K/AKT signaling. |
Stable transfection of CDX1, invasion assay (QCM ECMatrix), Western blot, qRT-PCR, PI3K inhibitor (perifosine) treatment |
Placenta |
Medium |
24836459
|
| 2022 |
EHF physically interacts with CDX1 via its PNT domain. EHF and CDX1 co-operatively drive transcription of the colonic differentiation marker VIL1. Compound genetic deletion of Ehf and Cdx1 in the mouse colon disrupts normal colonic differentiation and significantly enhances colorectal tumor progression. |
Co-immunoprecipitation (EHF-CDX1 interaction), chromatin remodeling assays, transcriptional assays for VIL1, Ehf/Cdx1 compound conditional knockout mice, tumor progression analysis |
Cell death and differentiation |
High |
35606410
|
| 2011 |
Class I and III HDACs contribute to epigenetic silencing of CDX1 in colorectal cancer. Unlike EPHB2-4 genes, the inactive CDX1 locus shows strong reduction of active histone modifications. Treatment with HDAC inhibitors combined with DNA methyltransferase inhibitors restores CDX1 expression depending upon the epigenetic features of its promoter. |
Quantitative expression profiling of matched normal/adenoma/carcinoma, histone modification ChIP, pharmacological treatment with DNMT and HDAC inhibitors in CRC cell lines |
Epigenetics |
Medium |
21393996
|
| 2014 |
Transient expression of CDX1 at E11.5 dpc in mouse embryonic hearts promotes epicardial epithelial-to-mesenchymal transition (EMT). Low-dose CDX1 induction enhances migration and differentiation of epicardium-derived cells into α-SMA+ vascular smooth muscle, while high-level or absence of CDX1 attenuates these abilities. RNA-seq showed CDX1 alters transcripts involved in neuronal development, angiogenesis, and cell adhesion. |
Doxycycline-inducible CDX1 mouse model, primary epicardium culture, ex vivo heart culture, RNA-seq |
PloS one |
Medium |
25068460
|
| 2011 |
Cdx1 negatively regulates the Pou5f1 (Oct3/4) gene network during gastrulation: Oct3/4 factors (Oct60, Oct25, Oct91) initially activate Cdx1 expression through FGF signaling before gastrulation, then become repressors during gastrulation. Cdx1 subsequently represses Pou5f1 genes, contributing to repression of pluripotency and promotion of gastrulation. |
Xenopus gain-of-function and morpholino knockdown, promoter analysis, FGF signaling pathway analysis |
Developmental dynamics |
Medium |
21360791
|
| 2004 |
Intestine-specific enhancers of CDX1 are located between -15601 and -5667 bp upstream of the CDX1 transcription start site. Transgenic mouse analysis showed that sequences between -5667 and +68 drive ectopic expression, while -15601 to +68 restricts expression to the intestinal epithelium. Two DNase I hypersensitive sites at ~-5.8 and -6.8 kb mark putative intestine-specific enhancers. |
Transgenic mouse analysis with CDX1 5' flanking sequences, DNase I hypersensitivity assay |
American journal of physiology. Gastrointestinal and liver physiology |
Medium |
14715525
|
| 2002 |
CDX1 transactivates the human PCNA gene promoter through Caudal-related homeodomain binding sequences in the PCNA 5'-flanking region in hepatocellular and colorectal carcinoma cell lines, while CDX2 does not. CDX1-induced PCNA expression was confirmed at the protein level, and CDX1 enhanced BrdU incorporation. |
Co-transfection of PCNA reporter with CDX1/CDX2 expression plasmids, Western blot, immunocytochemistry, BrdU incorporation assay |
International journal of oncology |
Low |
11743638
|
| 2008 |
Bile acid induces COX-2 expression in gastric cancer cells through a sequential pathway: bile acid induces the orphan nuclear receptor SHP, which then induces CDX1 expression; CDX1 in turn enhances COX-2 gene expression. This transcriptional cascade was verified by ectopic expression experiments. |
Promoter-reporter assays, ectopic expression of CDX1 and SHP, RT-PCR in human IM lesions |
Carcinogenesis |
Low |
18775915
|